we outline some available software and how it might be used practically as a solution for computational drug design. "
Editorial Schweiker & Levonis
Acidic and basic sidechains of amino acids may need to be modified, as their protonation will vary depending on the pH. Typically physiological pH is considered, and this will correspond to aspartic acid (Asp, D, pKa 3.90, deprotonated [negative charge]), glutamic acid (Glu, E, pKa 4.07, deprotonated [negative charge]), histidine (His, H, pKa 6.04, deprotonated [neutral charge]), lysine (Lys, K, pKa 10.79, protonated [positive charge]) and arginine (Arg, R, pKa 12.48, protonated [positive charge]). Before molecular docking, the target site needs to be prepared, which includes removing the ligand from the crystal structure (if present), removing the structural water molecules, adding hydrogen atoms to the sidechains, assigning atoms types and adding charges. Many of these final preparation steps can be performed automatically by the software. Once the target is prepared this file can then be used as the working target site for molecular docking. The ligand library that is to be used for docking must be prepared, with some different considerations. This process involves identifying atom types, structural minimization, adding hydrogens and assigning charges to offer reasonable starting conformation for the molecular docking experiment.
Rigid & flexible docking
The two main types of molecular docking experiments we consider are flexible and rigid target-site docking. In molecular docking experiments, the ligands are almost always made flexible and are minimized within the binding site to produce the best fit based on computed interactions. Rigid docking searching algorithms treat the target site as being rigid and immobile and fit the ligand into the predefined pocket. The calculations for rigid docking are faster to complete and may not represent an accurate pose or global minimum conformation. Flexible docking algorithms vary in their complexity and may consider the target to have only flexible hydrogen atoms or may have only preselected flexible residues. It is possible to consider the entire protein target of interest to be flexible, but this may require a long computation time and the accuracy of the results may vary. In recent years with advances in computational power, more advanced molecular dynamics simulations have become possible, taking into account the interactions of water molecules present in a completely flexible environment, and even considering the polarization of water [8, 9] .
Validation of model
The docking algorithm can be validated and assessed by comparing the extracted x-ray ligand (native ligand that was extracted from the original crystal structure) and the docked x-ray ligand to determine the root mean square deviation. A root mean square deviation of less than 2Å is generally considered as an acceptable validation of the docking run [10, 11] . Another process to assess the docking is to include known inhibitors and known decoy inhibitors in the docking run. Typically, for each docking run a library of ligands are produced, and within this library known inhibitors and known decoys are included. Once a docking run is complete, the ligands are ranked in terms of their binding affinity to the target site, and this allows the comparison of the ligands to one another. For example, with AutoDock Vina used with PyRx ligands display a binding affinity in kcal/mol, with the more negative the binding affinity representing a better the fit into the binding pocket [12] .
Interpretation of results
Results can be interpreted in terms of binding affinity and also key residue interactions. The key binding residues that are found within the site can be identified, and hydrogen-bonding interactions can be identified. This is in addition to determining where possible hydrophobic interactions may occur, performed by measuring the distance between the ligand and the residues functional group. Examining how the ligand folds or is positioned within the binding site and comparing the docked pose with known inhibitors or the decoys that were in the library can also give valuable insight.
Example protocol
In this section, we outline some available software and how it might be used practically as a solution for computational drug design. First, the PDB file of interest may be downloaded from the protein data bank, selecting a high-resolution PDB that is available for use [3] . The PDB file can then be opened with Chimera for preparation. Typically, a researcher might remove the ligand from the crystal structure, remove the structural water molecules, add hydrogen atoms to sidechains, assign atoms types and finally add charges before saving this as a new file. AutoDockTools may then be used to further manipulate and examine the PDB file if desired, before docking with AutoDock Vina via the PyRx graphical user interface. Binding data for the examined ligands are given in the form of kcal/mol, and can be used to guide further molecular design.
Conclusion
In recent times, the hurdle for entry into computational chemistry studies has become lowered to the point where routine experiments are possible in any academic environment where computers are present. This is particularly true for medicinal chemistry and drug design, with many programs available to run experiments locally on relatively low cost devices. In the interest of brevity, this editorial did not mention all of the multitudes of freely available databases and computer server systems that are available. Used for the collection of data and the computation of experiments on remote systems, this abundance of resources further lowers the device requirements for analysis. In the current era, these processes and technologies have largely become established. Computational tools are highly available and are primed for use by the end user, the academic researcher, to make discoveries and advance their field of knowledge.
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